ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

LIAN LianBio

0.319
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
LianBio LIAN NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.319 10:00:00
Open Price Low Price High Price Close Price Previous Close
0.319 0.319
more quote information »

Recent News

Date Time Source Heading
11/3/202422:51EDGAR2Form 25 - Notification of the removal from listing and..
28/2/202423:00GLOBELianBio Announces Voluntarily Delisting from Nasdaq
21/2/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202423:04EDGAR2Form 8-K - Current report
13/2/202423:00GLOBELianBio Announces Completion of Strategic Review
08/1/202422:13EDGAR2Form 144 - Report of proposed sale of securities
29/12/202323:56EDGAR2Form 144 - Report of proposed sale of securities
27/12/202308:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/12/202308:07EDGAR2Form 8-K - Current report
27/12/202306:40APSBiotech Finds Success Following Holiday Weekend
26/12/202318:00GLOBELianBio Enters into Agreement Assigning its Rights for..
21/12/202300:05EDGAR2Form 8-K - Current report
21/12/202300:00GLOBELianBio Announces Departure of Chief Financial Officer
20/12/202308:26EDGAR2Form 8-K - Current report
20/12/202308:05GLOBELianBio Announces Departure of Chief Executive Officer
07/12/202308:23EDGAR2Form 8-K - Current report
07/12/202308:05GLOBELianBio’s Board of Directors Unanimously Determines not to..
02/12/202308:16EDGAR2Form 8-K - Current report
02/12/202308:05GLOBELianBio Confirms Receipt of Unsolicited Proposal from..
14/11/202308:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202308:17EDGAR2Form 8-K - Current report
14/11/202308:05GLOBELianBio Reports Third Quarter 2023 Financial Results and..
31/10/202307:16EDGAR2Form 8-K - Current report
31/10/202307:05GLOBELianBio Announces Topline Results from Phase 3 LIBRA Trial..
26/10/202307:05GLOBELianBio Announces Presentation of Data from Phase 2a Study..
25/10/202301:25APSBiotech Shares Soar Premarket
25/10/202300:22DJNLianBio Shares Soar Premarket on Strategic Review, End of..
24/10/202321:59GLOBELianBio Enters into Agreement with Bristol Myers Squibb for..
29/8/202306:05GLOBELianBio Announces Results from Phase 3 EXPLORER-CN Trial of..
15/8/202306:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/8/202306:11EDGAR2Form 8-K - Current report
15/8/202306:05GLOBELianBio Reports Second Quarter 2023 Financial Results and..
04/8/202306:05GLOBELianBio Announces First Patient Treated in Phase 1 Trial of..
26/7/202322:30GLOBELianBio Partner Tarsus Pharmaceuticals Announces U.S. FDA..
18/7/202322:00GLOBELianBio Partner NANOBIOTIX Enters into License Agreement..
17/7/202320:00GLOBELianBio Announces Phase 3 EXPLORER-CN Data Accepted for..
12/7/202322:00GLOBELianBio Announces Clinical Supply Agreement with AstraZeneca..
26/6/202322:00GLOBELianBio Announces Marketing Approval of CAMZYOS®..
08/6/202321:00GLOBELianBio Completes Enrollment in Pivotal Phase 3 LIBRA Trial..
08/6/202308:21DJNADRs End Mostly Lower, Oatly and LianBio Trade Actively
07/6/202306:05GLOBELianBio Announces Topline Results from Phase 2a Proof of..
02/6/202306:15GLOBELianBio to Participate in Upcoming Investor Conferences
12/5/202306:15GLOBELianBio Reports First Quarter 2023 Financial Results and..
11/5/202321:00GLOBELianBio Announces Marketing Approval of CAMZYOS®..

Your Recent History

Delayed Upgrade Clock